The elevated plasma concentrations of CRP and the cytokines evaluated in the present study have also been observed in other inflammatory conditions, such as rheumatoid arthritis, systemic lupus erythematosus, visceral leishmaniasis, and COVID-19 [4,6,8,50]. This evidence concerns the gene CRP and COVID-19.